Since several human herpesviruses, including varicellazoster virus (VZV), have been demonstrated to transform mammalian cells in vitro, VZV was tested in a mouse model of virus-induced cervical neoplasia to determine whether it is oncogenic in vivo. Herpes simplex viruses types 1 and 2 and cytomegalovirus have been previously shown to induce cervical neoplasia in this mouse model. VZV was propagated in WI-38 cell cultures and inactivated by ultraviolet irradiation. Control material was prepared in an identical manner from uninfected cell cultures. Cotton tampons, saturated with inactivated virus or control material, were inserted into the vaginas of C57BL mice three times a week for 60 weeks. Cervical dysplasia was detected in 40 % and invasive carcinoma in 34 % of virus-exposed mice by histological examination. No lesions were detected in control animals. These observations indicate that VZV, or some product of virus-infected cells, is oncogenic in vivo for the mouse cervix.
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Varicella-zoster virus (VZV) is the cause of chickenpox, an infection contracted by 95~o of people during childhood or adolescence (Gershon et al., 1976) . Although herpes zoster is a frequent complication in patients with impairment of the immune system secondary to malignant disease or its treatment, there is no epidemiological evidence to suggest that VZV is an oncogenic virus. However, it belongs to the human herpesvirus group, of which four members, herpes simplex viruses types 1 and 2 (HSV-1, HSV-2), cytomegalovirus (CMV) and Epstein-Barr virus (EBV), have been shown to have oncogenic properties (zur Hausen, 1980; Macnab, 1987) . All four of these viruses induce transformation of cells in culture (Henle, 1967; Duff & Rapp, 1971 Rapp & Albrecht, 1973; Geder et al., 1976) and three (HSV-2, CMV and EBV) have been reported in many, but not all, studies to have seroepidemiological associations with human malignancies (zur Hausen, 1980; Rapp & Jenkins, 1981; Vonka et al., 1984; Dale et at., 1988) . In a mouse model of cervical carcinogenesis, a progression from dysplasia to microinvasive to invasive carcinoma has been induced by repeated exposure of the cervix to inactivated HSV-1, HSV-2 or CMV (Wentz et al., 1975 (Wentz et al., , 1981 (Wentz et al., , 1983 Heggie et al., 1986) . Transfection is thought to be the mechanism by which neoplasia is initiated in this model (Anthony et al., 1989) . As VZV is a human herpesvirus that has also been shown to induce transformation of mammalian 0000-9481 © 1990 SGM cells in vitro (Gelb et al., 1980; Gelb & Dohner, 1984) , it was tested in this mouse model to determine whether, under appropriate conditions, VZV can induce oncogenesis in vivo.
VZV (VR-586) and WI-38 human diploid lung cells (line CCL-75) were obtained from the American Type Culture Collection. For propagation of VZV, monolayer cultures of WI-38 cells, grown in Eagle's MEM containing 10~o (v/v) foetal calf serum, were inoculated with trypsin-EDTA-dispersed cells from VZV-infected WI-38 cell cultures in a ratio of one infected cell to six uninfected cells (Schmidt & Lennette, 1976) . After incubation of cultures for 48 h at 36 °C in 5 ~o carbon dioxide, VZV was harvested by dispersal of infected cell monolayers into the culture fluids by shaking with glass beads. The virus titre of the harvested cultures was determined by immediate inoculation of serial 10-fold dilutions of the suspension of infected cells into fresh WI-38 cell cultures. The harvested cell suspensions were then centrifuged at 1000 g at 4 °C for 15 min. The supernatant fluid was stored at 4°C; the pellet of cells was resuspended in culture fluid, frozen and thawed three times, and sonicated for 30 s (Fisher Model 300 Sonic Dismembrator, 50~ power, cup tip adapter on probe). The sonicated cells were pelleted, the pellet was washed three times with aliquots of culture fluid and the washes were added to the stored culture fluids. For inactivation of infectivity, 90 ml of the extract of VZV-infected cells was dispensed into 22 x 34 cm sterile glass dishes and exposed to an ultraviolet light source consisting of two G 15T8 germicidal lamps (General Electric Company) at a distance of 20 cm for 12 min. Extracts contained approximately 106 TCIDso of virus per ml before inactivation. No infectious virus was detected after inactivation. Control fluid for exposure of mice was prepared in an identical way, including ultraviolet irradiation, except that WI-38 cell cultures were not inoculated with VZV. Preparations of inactivated VZV and control fluid were stored at -70 °C until used for exposure of mice. C57BL virgin female mice were used in this study. Mice, approximately 6 weeks old at the time of receipt, were assessed for pre-existing abnormalities by examination of cytological preparations of vaginal aspirates obtained weekly for 4 weeks. After completion of this assessment, cotton tampons, saturated with approximately 0.1 ml of a VZV preparation that contained 105 TCIDso of virus before inactivation, or with the same volume of control fluid, were inserted into the vaginas of mice three times a week for 60 weeks. Sixty mice were exposed to inactivated VZV and 40 to control fluid. Smears of vaginal aspirates were obtained at 10 week intervals and examined for cytological abnormalities. Mice were killed after 60 weeks of exposure and histological preparations of their entire reproductive tracts were examined without knowledge of the treatment received. The details of these procedures and the criteria by which cytological and histological diagnoses were made have been described previously (Wentz et al., 1975 (Wentz et al., , 1981 .
The results of cytological examinations of smears of vaginal aspirates obtained after increasing durations of exposure to inactivated VZV preparations are shown in Table 1 . Increasing durations of exposure were associated with increasing frequencies of cytological abnor- 37 (100.0) 0 (0) 0 (0) * Differences in frequencies, both of dysplasia and invasive carcinoma, between VZV-exposed and control mice are statistically significant when tested separately by the Chi-square test (P < 0.001).
realities. Nocytological abnormalities were detected at any time in mice exposed to control fluid. The frequencies of cervical lesions detected by histological examination at the end of the exposure period are shown in Table 2 . Cervical dysplasia was present in 40% and invasive carcinoma in 34% of mice exposed to inactivated VZV preparations. No abnormalities were detected in control animals. These differences between the VZVtreated and control groups in frequencies of dysplasia and carcinoma were statistically significant when tested separately by the Chi-square test (P < 0.001). Photomicrographs of representative histological sections of cervices showing dysplasia, microinvasive carcinoma and invasive carcinoma are presented in Fig. 1 . During the course of the experiment, 13 animals died of intercurrent infections and their tissues were unavailable for histological study due to autolysis or cannibalism. However, none of the cytological examinations performed prior to the deaths of the control animals showed evidence of neoplasia.
The results of this study indicate tl~at VZV, or some product of VZV-infected cells, is oncogenic for the mouse cervix in vivo. This observation is consistent with the finding that VZV-infected cells can transform mammalian cells in vitro (Gelb et al., 1980; Gelb & Dohner, 1984) . VZV is the fourth human herpesvirus that has been found to be carcinogenic in this mouse model of cervical neoplasia. A recent study showed that repeated exposure of the mouse cervix to purified genomic HSV-2 DNA was as effective as inactivated whole HSV-2 virions in the induction of cervical neoplasia (Anthony et al., 1989) . This suggests that transfection may be the initiating event in neoplasia induced by HSV-2. In contrast, Gelb et al. (1980) and Gelb & Dohner (1984) found that transformation of hamster cells in vitro was induced by human embryonic lung ceils infected by a recent clinical isolate of VZV but not by cell-free VZV, VZV DNA, or laboratory passaged strains of VZV. This suggests, among other possibilities, that products of infected cells may be important in VZVassociated cellular transformation. This study was supported in part by the Cuyahoga County Chapter of the American Cancer Society.
